During hemodialysis procedures, changes in the dialysate temperature can raise or lower body temperature because the blood is returned to the patient in thermal equilibrium with the dialysate. Even a dialysate temperature equal to the patient's body temperature as measured from the tympanic membrane, oral cavity, or axilla can result in an increase in the patient's body temperature, leading to cutaneous vasodilation and the potential for cardiovascular instability and hypotension. This deleterious cycle of events can be prevented by suitably adjusting the dialysate temperature. Lowering the dialysate temperature from 37 degrees C to 34-35.5 degrees C has improved the cardiovascular stability of many hemodialysis patients. Continuous monitoring of blood temperature allows the practitioner to make preemptive changes in dialysate temperature because a small change in body temperature can have enormous cardiovascular implications. For example, only 0.3 degrees C to 0.8 degrees C separates the thresholds for skin vasodilation from that for shivering. A suggested improvement in the hemodialysis procedure is to use devices that allow continuous monitoring of arterial and venous blood temperatures and adjust the dialysate temperature automatically, keeping the patient, not the dialysate, isothermic. Less optimal solutions appear to be (1) to monitor arterial and venous temperatures while manually adjusting the dialysate temperature to maintain arterial (and hence body) temperature stability; (2) to monitor peripheral temperatures (oral, tympanic) at regular intervals and adjust dialysate temperature to maintain the body temperature constant; (3) routinely use a dialysate temperature <37.0 degrees C in all patients unless contraindicated.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.ajkd.2004.03.036 | DOI Listing |
Appl Microbiol Biotechnol
December 2024
Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.
In the present investigation, 13% ± 0.84 of the extracted and purified phycocyanin from Phormidium versicolor was obtained, with a purity of 0.69 following dialysis.
View Article and Find Full Text PDFBMC Nephrol
December 2024
Department of Old Age Psychiatry, Heartlands Hospital, Birmingham, B9 5SS, UK.
Background: Cognitive impairment is common in haemodialysis patients with no known beneficial interventions. Cooler dialysate slows brain white-matter changes, but its effect on cognition is unknown. This feasibility trial was performed to inform a fully-powered, randomised trial to assess this.
View Article and Find Full Text PDFJ Am Chem Soc
January 2025
Polymer Reaction Design Group, School of Chemistry, Monash University, 19 Rainforest Walk, Building 23, Clayton, VIC 3800, Australia.
A continuous flow setup comprising an inline dialysis unit for immediate monomer removal is used for the depolymerization of poly(methyl methacrylate) (pMMA), synthesized via reversible addition-fragmentation chain transfer (RAFT) polymerization. The approach used allows one to carry out solution depolymerizations at much higher polymer content compared to batch processes while maintaining high depolymerization conversions. pMMA is efficiently depolymerized in the flow reactor, yielding up to 68% monomer recovery under catalyst-free reaction conditions at 160 °C, starting from a 1 molar repeat unit concentration, which is a 20-fold improvement compared to previous batch studies.
View Article and Find Full Text PDFActa Biochim Pol
December 2024
Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdansk, Gdańsk, Poland.
Various high-efficiency hemodialysis techniques exist, including different online high- volume hemodiafiltration (HDF) modes and expanded hemodialysis (HDx) utilizing dialyzers with medium cut-off (MCO) membranes. This study aimed to evaluate the efficacy of uremic toxin removal among four modalities: (I) HDx, (II) pre-dilution HDF (PRE-HDF), (III) mixed-dilution HDF (MIX-HDF), and (IV) post-dilution HDF (POST-HDF), each applied for 1 week in a randomized order. This research was a single-center, prospective, open-label, exploratory crossover study.
View Article and Find Full Text PDFRen Fail
December 2024
Department of Nephrology, 900th Hospital of Joint Logistics Support Force, Fuzhou, Fujian Province, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!